Indivior Inc. is a pharmaceutical company that develops medicines for substance use disorders. Its filings show it lobbies Congress on Medicare and Medicaid reimbursement rules and on policies affecting addiction treatment, including the Medicaid Reentry Act and funding for agencies like the National Institutes of Health and the Department of Health and Human Services. It has disclosed hiring DLA Piper LLP and reported $240,000 in lobbying since 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
KARINA LYNCH
The latest disclosures for this client.
DLA PIPER LLP (US)
Q4DLA PIPER LLP (US)
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
DLA PIPER LLP (US)
mrs NICOLE MARIE RUZINSKI BERTSCH
DLA PIPER LLP (US)
RACHEL PORTMAN
DLA PIPER LLP (US)
DLA PIPER LLP (US)
Q2DLA PIPER LLP (US)
Q1